leucegene.com
Publications - Leucegene Project
http://www.leucegene.com/leucegene/publications.php
PIs and Lab Members. Maiga A, Lemieux S, Pabst C, Lavallée VP, Bouvier M, Sauvageau G, Hébert J. (2016). Transcriptome analysis of G protein-coupled receptors in distinct genetic subgroups of acute myeloid leukemia: identification of potential disease-specific targets. Blood Cancer J. 2016 Jun 3;6(6):e431. doi: 10.1038/bcj.2016.36. Blood 2016 Jun 16;127(24):3054-61. doi: 10.1182/blood-2016-03-705053. Epub 2016 Mar 31. Leukemia. 2016 Feb 9. doi: 10.1038/leu.2016.19. Pabst C, Bergeron A, Lavallée VP, Yeh J...
cdrd.ca
CDRD & IRICoR to Co-Develop Innovative Made-in-Canada Therapeutics - CDRD-Canada's national drug development & commercialization engine
http://www.cdrd.ca/news/cdrd-iricor-to-co-develop-innovative-made-in-canada-therapeutics
Transforming Discovery into Opportunity. News & Events. Project Approval Criteria and Process. Project Search and Evaluation Team. Support for Canadian Health Sciences Companies. The CDRD Drug Development Training Program. The CDRD Employment Hub. CDRD & IRICoR to Co-Develop Innovative Made-in-Canada Therapeutics. The projects are :. Identification of biomarkers and small molecule inhibitors for a novel form of resistance in cancer therapies Dr. Katherine Borden. Principal Investigator at the CHU de Québ...
iric.ca
IRIC | Institute for Research in Immunology and Cancer
https://www.iric.ca/en
IRIC at a glance. Key moments in IRIC’s history. Making a significant impact on the treatment of cancer. A distinctive research model. A word from our Director. How to get to IRIC. Cellular Mechanisms of Morphogenesis during Mitosis and Cell Motility. Structure and Function of the Cell Nucleus. Recombinant Proteins and Antibodies. Application M.Sc. & Ph.D. Why study at IRIC. IRIC on the road. 10 reasons to study at IRIC. Photo album of the 2016 IRIC Student Recruitment Event. IRIC Next Generation Awards.
leucegene.com
Resources - Leucegene Project
http://www.leucegene.com/leucegene/resources.php
PIs and Lab Members. Research resources and scientific data generated through the Leucegene project are made accessible to the scientific community after publication through international repositories. Is accessible through GEO. More specifically, the following datasets are already available:. Leucegene: ALL sequencing - Accession # GSE49601. Transcriptome of Primitive Human Hematopoietic Cells: A New Resource to Find hHSC-Specific Genes - Accession: # GSE48846. Bioinformatics software and databases.
leucegene.com
LEUCEGENE Project
http://www.leucegene.com/leucegene/index.php
PIs and Lab Members. Novel Prognostic Classification of AML. Novel Prognostic Classification of AML. Acute Myeloid Leukemia (AML). Is a particularly lethal form of cancer, with most patients dying within two years of diagnosis. It is one of the leading causes of death among young adults. Existing prognostic tests are often inaccurate, leaving doctors with no tools to guide their decision making about treatment options. June 3, 2016 - Recent publication of the Leucegene team in Blood Cancer Journal. In th...
leucegene.com
Participants - Leucegene Project
http://www.leucegene.com/leucegene/people
PIs and Lab Members. Principal Investigators and lab members. Guy Sauvageau, M.D., Ph.D., F.R.C.P.(C). Principal investigator, Institute for Research in Immunology and Cancer (IRIC). Director, Molecular Genetics of Stem Cells research unit, IRIC. Josée Hébert, M.D., F.R.C.P.(C). Hematologist and cytogeneticist, Maisonneuve-Rosemont Hospital. Director, Quebec Leukemia Cell Bank (BCLQ). Collaborator, flow cytometry. Anne Marinier, Ph.D. Principal investigator and director of medicinal chemistry, IRIC.
leucegene.com
Archives - Leucegene Project
http://www.leucegene.com/leucegene/archives.php
PIs and Lab Members. February 1, 2016 - Recent publication of the Leucegene team in Blood. Published GPR56 identifies primary human acute myeloid leukemia cells with high repopulating potential in vivo. In the scientific journal Blood. December 8, 2015 - Vincent Lavallée. September 8, 2015 - Recent publication of the Leucegene team in Nature Genetics. Published The transcriptomic landscape and directed chemical interrogation of MLL-rearranged acute myeloid leukemias. To the poster session. March 31, 2015...
excellthera.ca
Our Partners | ExCellThera
http://excellthera.ca/our-partners
Mission & Vision. ExCellThera was established through a partnership between the Institute for Research in Immunology and Cancer – Commercialization of Research (IRICoR). And the Centre for Commercialization of Regenerative Medicine (CCRM). ExCellThera is developing product and service solutions based on novel proprietary intellectual property developed at the University of Montreal’s (UdeM) Institute for Research in Immunology and Cancer. Centre for Commercialization of Regenerative Medicine.
leucegene.ca
Participants - Leucegene Project
http://www.leucegene.ca/leucegene/people
PIs and Lab Members. Principal Investigators and lab members. Guy Sauvageau, M.D., Ph.D., F.R.C.P.(C). Principal investigator, Institute for Research in Immunology and Cancer (IRIC). Director, Molecular Genetics of Stem Cells research unit, IRIC. Josée Hébert, M.D., F.R.C.P.(C). Hematologist and cytogeneticist, Maisonneuve-Rosemont Hospital. Director, Quebec Leukemia Cell Bank (BCLQ). Collaborator, flow cytometry. Anne Marinier, Ph.D. Principal investigator and director of medicinal chemistry, IRIC.
cyclenium.com
Partners — Cyclenium Pharma
http://www.cyclenium.com/partners
À Propos De Nous. À Propos De Nous. For more information on Astellas Pharma Inc., please visit the company website at www.astellas.com/en. For more information on Haplogen visit: www.haplogen.com. For additional information visit: www.medinadiscovery.com. McGill University/Goodman Cancer Research Centre. More information on McGill University is available at www.mcgill.ca. Additional information on the GCRC is available at www.mcgillgcrc.com. For more information on the McGill Life Science Complex HTS Fac...
